Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Neuro-Oncology|July 6, 2024
PET imaging of gliomas: Status quo and quo vadis?Norbert Galldiks, Philipp Lohmann, Michel Friedrich, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2026
Assessment of Response to Regorafenib in Patients with Glioma Relapse Using 18F-FET PET and MRIJan-Michael Werner, Philipp Lohmann, Christoph Kabbasch, et al.Neuro-Oncology|August 23, 2019
Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogressionNorbert Galldiks, Martin Kocher, Garry Ceccon, et al.Cancers|December 23, 2020
FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-ChemoradiationPhilipp Lohmann, Mai A Elahmadawy, Robin Gutsche, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 4, 2025
Diagnosis of treatment-related changes in children and adolescents with brain and spinal tumors: a cost-effectiveness analysis using MRI and [18 F]FET PETJurij Rosen, Jan-Michael Werner, Garry S Ceccon, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2020
Early Treatment Response Assessment Using 18F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide ChemotherapyGarry Ceccon, Philipp Lohmann, Jan-Michael Werner, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 2, 2020
Flare Phenomenon in O-(2-18F-Fluoroethyl)-l-Tyrosine PET After Resection of GliomasChristian P Filss, Ann K Schmitz, Gabriele Stoffels, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PETJan-Michael Werner, Johannes Weller, Garry Ceccon, et al.Cancers|March 10, 2022
Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting SubgroupsMaike Trommer, Anne Adams, Eren Celik, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
Cost Effectiveness of 18F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide ChemotherapyJurij Rosen, Garry Ceccon, Elena K Bauer, et al.Pageof 6